Tosic Isidora,Frank David A (2021) STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications, NEOPLASIA, vol. 23, br. 12, str. 1167-1178 (Article) 

Liu Suhu,Gandler Helen I,Tosic Isidora,Ye Darwin Q,Giaccone Zachary T,Frank David A (2021) Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer, MOLECULAR CANCER RESEARCH, vol. 19, br. 8, str. 1283-1295 (Article) 

Tosic Isidora,Heppler Lisa N,Egusquiaguirre Susana P,Boehnke Natalie,Correa Santiago,Costa Daniel F,Grossman-Moore Elizabeth A,Pal Sharmistha,Richardson Douglas S,Ivanov Alexander R,Haas-Kogan Daphne A,Nomura Daniel K,Hammond Paula T,Frank David A (2021) Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-L-glutamic Acid-coated Layer-by-Layer Nanoparticles, MOLECULAR CANCER THERAPEUTICS, vol. 20, br. 4, str. 726-738 (Article) 

Cerulli Robert A,Shehaj Livia,Tosic Isidora,Jiang Kevin,Wang Jing,Frank David A,Kritzer Joshua A (2020) Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors, BIOORGANIC & MEDICINAL CHEMISTRY, vol. 28, br. 12, str. - (Article) 

Stevens Alexandra M,...,Tosic Isidora,...,(broj koautora 22) (2019) Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation, BLOOD ADVANCES, vol. 3, br. 24, str. 4215-4227 (Article)